Maternal and fetal genetic contribution to gestational weight gain
- PMID: 28990592
- PMCID: PMC5784805
- DOI: 10.1038/ijo.2017.248
Maternal and fetal genetic contribution to gestational weight gain
Abstract
Background: Clinical recommendations to limit gestational weight gain (GWG) imply high GWG is causally related to adverse outcomes in mother or offspring, but GWG is the sum of several inter-related complex phenotypes (maternal fat deposition and vascular expansion, placenta, amniotic fluid and fetal growth). Understanding the genetic contribution to GWG could help clarify the potential effect of its different components on maternal and offspring health. Here we explore the genetic contribution to total, early and late GWG.
Participants and methods: A genome-wide association study was used to identify maternal and fetal variants contributing to GWG in up to 10 543 mothers and 16 317 offspring of European origin, with replication in 10 660 mothers and 7561 offspring. Additional analyses determined the proportion of variability in GWG from maternal and fetal common genetic variants and the overlap of established genome-wide significant variants for phenotypes relevant to GWG (for example, maternal body mass index (BMI) and glucose, birth weight).
Results: Approximately 20% of the variability in GWG was tagged by common maternal genetic variants, and the fetal genome made a surprisingly minor contribution to explain variation in GWG. Variants near the pregnancy-specific beta-1 glycoprotein 5 (PSG5) gene reached genome-wide significance (P=1.71 × 10-8) for total GWG in the offspring genome, but did not replicate. Some established variants associated with increased BMI, fasting glucose and type 2 diabetes were associated with lower early, and higher later GWG. Maternal variants related to higher systolic blood pressure were related to lower late GWG. Established maternal and fetal birth weight variants were largely unrelated to GWG.
Conclusions: We found a modest contribution of maternal common variants to GWG and some overlap of maternal BMI, glucose and type 2 diabetes variants with GWG. These findings suggest that associations between GWG and later offspring/maternal outcomes may be due to the relationship of maternal BMI and diabetes with GWG.
Conflict of interest statement
DAL has received support from Roche Diagnostics and Medronic Ltd for biomarker research unrelated to this study. HMI and SJB have received research funding from Abbott Nutrition, Nestec and Danone Nutricia, for research unrelated to this study. The remaining authors declare no conflict of interest.
References
-
- Rasmussen KM, Yaktine AL. Weight gain during pregnancy: reexamining the guidelines. Committee to reexamine IOM pregnancy weight guidelines: US Institute of Medicine and National Research Council 2009. - PubMed
-
- Viswanthan M, Siega-Riz AM, Moos M-K, Deierlein A, Mumford S, Knaack J et al Outcomes of Maternal Weight Gain, Evidence Report/Technology Assessment No. 168. AHRQ Publication No08-E009 ed. Rockville, MD, USA: Agency for Healthcare Research and Quality 2008.
-
- Lawlor DA, Relton C, Sattar N, Nelson SM. Maternal adiposity–a determinant of perinatal and offspring outcomes? Nat Rev Endocrinol 2012; 8: 679–688. - PubMed
Publication types
MeSH terms
Grants and funding
- RG/15/17/31749/BHF_/British Heart Foundation/United Kingdom
- 19169/CRUK_/Cancer Research UK/United Kingdom
- MR/J012165/1/MRC_/Medical Research Council/United Kingdom
- 088806/WT_/Wellcome Trust/United Kingdom
- MC_PC_15018/MRC_/Medical Research Council/United Kingdom
- MC_UP_A620_1017/MRC_/Medical Research Council/United Kingdom
- 648916/ERC_/European Research Council/International
- MC_UU_12013/4/MRC_/Medical Research Council/United Kingdom
- R01 DK103246/DK/NIDDK NIH HHS/United States
- MC_UU_12011/4/MRC_/Medical Research Council/United Kingdom
- MC_UU_12013/5/MRC_/Medical Research Council/United Kingdom
- G9815508/MRC_/Medical Research Council/United Kingdom